Laden...
Drug giant AstraZeneca is reviewing the "single event" that caused the illness during Phase 3 of Oxford's coronavirus vaccine trials. The interruption represents the first major hiccup in what has been a smooth path in the rapid vaccine effort spanning the globe. |
|
Laden...
Laden...